ハイドロキシアパタイト市場- 世界の産業規模、シェア、動向、機会、予測、タイプ別、用途別、地域別、競合別、2019～2029年

ハイドロキシアパタイトの世界市場は2023年に24億5,000万米ドルと評価され、2029年のCAGRは6.13%で、予測期間には堅調な成長が予測されています。

カルシウムアパタイトの鉱物形態であるハイドロキシアパタイトは、1つのリン酸基と1つの水酸基から構成されています。歯の主要成分であり、高い剛性と唾液よりも優れたエナメル質の再石灰化をもたらします。

世界のハイドロキシアパタイト材料市場の拡大は、骨移植と骨移植材料に対する需要の高まりが主要要因です。この需要の急増は、米国やカナダのような地域における高齢化社会への人口動態の変化が主要要因となっています。これらの国では高齢者人口が着実に増加しており、整形外科用インプラントの需要もそれに伴って増加しているため、ハイドロキシアパタイト市場の成長にとって重要な促進要因となっています。

例えば、米国のデータでは、過去10年間だけでも高齢者人口が33%も増加していることが明らかになっており、整形外科的介入に対する差し迫ったニーズが強調され、その結果、ハイドロキシアパタイト材料の需要が高まっています。

新興経済諸国だけでなく先進国でも可処分所得水準が上昇しているため、化粧品、特にアンチエイジングやスキンケア製品への消費支出が増加しています。この消費者需要の急増は、製品ポートフォリオと製造施設の世界の急速な拡大を引き起こし、結果的にハイドロキシアパタイト材料の市場シェアを強化しています。

北米と欧州諸国における新しい医療サービスの採用は、ハイドロキシアパタイト市場規模の成長を促進すると予想されています。北米と欧州の国々は、GDPのかなりの部分、約11～15％を医療と研究機関に割り当てており、市場の成長を促進しています。例えば2018年、米国は医療費を約4.6%増加させました。製品品質の進歩により、優れた歯科用と整形外科用インプラントが開発されています。例えば、高度なゾル-ゲルプロセスで調製されたハイドロキシアパタイトは、粒子径やコーティング形成の点で優位性があり、眼用インプラントや非一体型インプラントに広く適用できます。

ハイドロキシアパタイトインプラントのコストが高いことと、インプラント手術に伴ういくつかの合併症が市場成長の妨げになると予想されます。インプラントに関連する高コストや、材料のラッピングやペグの交換などの追加費用が、コスト削減や合併症の少ない多孔質インプラントの需要増加につながる可能性があります。

主要市場の促進要因

医療産業におけるハイドロキシアパタイトの需要拡大

化粧品業界におけるハイドロキシアパタイトの需要拡大

主要市場課題

高品質の原材料の入手が限られていること

主要市場動向

生体適合性コーティングの需要拡大

セグメント別洞察

タイプ別洞察

用途別洞察

地域別洞察

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 ハイドロキシアパタイトの世界市場展望

• 市場規模予測
  • 金額別数量
• 市場シェア予測
  • タイプ別（ナノサイズ、マイクロサイズ、マイクロメートル以上）
  • 用途別（整形外科、形成外科、歯科、その他）
  • 地域別
  • 企業別（2023年）
• 市場マップ
  • タイプ別
  • 用途別
  • 地域別

第5章 アジア太平洋のハイドロキシアパタイト市場展望

• 市場規模予測
  • 金額数量別
• 市場シェア予測
  • タイプ別
  • 用途別
  • 国別
• アジア太平洋：国別分析
  • 中国
  • インド
  • オーストラリア
  • 日本
  • 韓国

第6章 欧州のハイドロキシアパタイト市場展望

• 市場規模予測
  • 金額ベース数量ベース
• 市場シェア予測
  • タイプ別
  • 用途別
  • 国別
• 欧州：国別分析
  • フランス
  • ドイツ
  • スペイン
  • イタリア
  • 英国

第7章 北米のハイドロキシアパタイト市場展望

• 市場規模予測
  • 金額ベース数量ベース
• 市場シェア予測
  • タイプ別
  • 用途別
  • 国別
• 北米：国別分析
  • 米国
  • メキシコ
  • カナダ

第8章 南米のハイドロキシアパタイト市場展望

• 市場規模予測
  • 金額ベース数量ベース
• 市場シェア予測
  • タイプ別
  • 用途別
  • 国別
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第9章 中東・アフリカのハイドロキシアパタイト市場展望

• 市場規模予測
  • 金額ベース数量ベース
• 市場シェア予測
  • タイプ別
  • 用途別
  • 国別
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第10章 市場力学

• 促進要因
• 課題

第11章 市場動向と新興国市場開拓

• 製品発表
• 合併・買収

第12章 ハイドロキシアパタイトの世界市場のSWOT分析

第13章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第14章 競合情勢

• Sofsera Corporation
• Taihei Chemical Industrial Co. Ltd
• Cam Bioceramics BV
• APS Materials Inc.
• Granulab（M）Sdn Bhd
• Berkeley Advanced Biomaterials Inc.
• Zimmer Biomet Holdings Inc
• CG Bio Inc.
• Bio-Rad Laboratories Inc.
• Fluidinova S.A.

第15章 戦略的提言

第16章 戦略的提言当社について免責事項

Global Hydroxyapatite Market was valued at USD2.45 billion in 2023 and is anticipated to project robust growth in the forecast period with a CAGR of 6.13% through 2029. Hydroxyapatite, the mineral form of calcium apatite, consists of one phosphate and one hydroxyl group. It is a major component of teeth, offering high rigidity and better enamel remineralization than saliva.

The expansion of the global hydroxyapatite materials market is predominantly fueled by the escalating demand for bone transplants and bone grafting materials. This surge in demand is notably propelled by several key factors, chief among them being the demographic shift towards an aging population in regions like the United States and Canada. As these nations witness a steady rise in the elderly population, there is a corresponding uptick in the requirement for orthopedic implants, thus acting as a significant driver for the growth of the hydroxyapatite market.

For instance, data from the United States reveals a notable increase of 33% in the elderly population over the past decade alone, underscoring the pressing need for orthopedic interventions and subsequently boosting demand for hydroxyapatite materials.

The escalation of disposable income levels in emerging economies as well as developed nations has resulted in heightened consumer spending on cosmetic products, particularly anti-aging and skincare solutions. This burgeoning consumer demand has triggered a rapid expansion of product portfolios and manufacturing facilities worldwide, consequently bolstering the market share of hydroxyapatite materials.

The introduction of new healthcare services in North America and European countries is anticipated to fuel the growth of the hydroxyapatite market size. Countries in North America and Europe are allocating a significant portion of their GDP, around 11-15%, to healthcare and research institutes, thus fueling the growth of the market. For instance, in 2018, the U.S. increased healthcare expenditure by around 4.6%. Advancements in product quality have led to the development of superior dental and orthopedic implants. For instance, hydroxyapatite prepared through an advanced sol-gel process provides advantages in terms of particle size and coating formation, making it widely applicable for ocular implants and non-integrated implants.

The high cost of hydroxyapatite implants and several complications involved in the implantation procedure are expected to hamper the market growth. The high cost associated with the implant and additional expenses, such as material wrapping and peg replacement, may lead to an increase in demand for porous implants with reduced cost and fewer complications.

Key Market Drivers

Growing Demand of Hydroxyapatite in Healthcare Industry

One of the key factors driving the demand for hydroxyapatite in the healthcare industry is the rising incidence of bone-related disorders such as osteoporosis and arthritis. As the global population ages, the prevalence of these conditions is expected to rise, thereby increasing the demand for effective treatment options. This is where hydroxyapatite-based implants and bone grafts come into play, offering a promising solution.

The use of hydroxyapatite is not just limited to orthopedics. It also finds extensive application in dental care. With advancements in dental care technologies and an increasing focus on oral hygiene, the demand for hydroxyapatite-based dental implants and toothpastes is on the rise. Hydroxyapatite-based dental implants provide a natural and aesthetically pleasing solution for tooth replacement, while hydroxyapatite toothpastes contribute to maintaining strong and healthy teeth.

There is an increased focus on the development and use of biocompatible implants in the healthcare industry. These are implants that can function in harmony with the human body without causing any adverse reactions. Hydroxyapatite, with its excellent biocompatibility, fits this requirement perfectly and hence, has seen a surge in demand. The ability of hydroxyapatite to integrate with surrounding tissues and promote bone regeneration makes it an ideal choice for various medical applications.

Growing Demand of Hydroxyapatite in Cosmetic Industry

Hydroxyapatite (HAp) is a naturally occurring mineral form of calcium apatite, known for its excellent biocompatibility and bioactivity. In the cosmetics industry, hydroxyapatite has emerged as a key ingredient in several products, particularly those related to dental and skincare applications.

Hydroxyapatite is gaining immense popularity in skincare products. It is used in anti-aging creams and serums due to its ability to support skin regeneration and collagen production. Nano-hydroxyapatite particles are used in sunscreens as they provide effective protection against harmful UV rays.

The global cosmetic industry has been witnessing a shift towards natural and sustainable products. Consumers are increasingly looking for products that are not only effective but also safe and eco-friendly. Hydroxyapatite, being a naturally occurring substance, aligns perfectly with this trend, thus driving its demand in the cosmetics sector.

The growing demand for hydroxyapatite in the cosmetic industry is a significant driver of the global hydroxyapatite market. As the cosmetic industry continues to evolve with an increased focus on natural and sustainable products, the demand for hydroxyapatite is expected to increase further, propelling the global market. This rise in demand is also attributed to the versatility of hydroxyapatite, as it finds applications not only in dental and skincare products but also in various other areas, such as tissue engineering. With ongoing research and development efforts, the potential of hydroxyapatite in the cosmetic industry is likely to expand, leading to further innovations and advancements in this field.

Key Market Challenges

Limited Availability of High-Quality Raw Materials

The global hydroxyapatite market has been experiencing significant growth in recent years, fueled by the increasing demand across various industries such as healthcare, cosmetics, and biotechnology. Amidst this growth, the hydroxyapatite industry also faces certain challenges that pose potential hindrances to its further development. One of the most prominent challenges is the limited availability of high-quality raw materials. Hydroxyapatite, being a naturally occurring mineral form of calcium apatite, heavily relies on the quality of its raw materials to determine the final product's properties and performance.

The global availability of such high-quality raw materials required for hydroxyapatite production is relatively limited. Several factors contribute to this limitation, including the depletion of natural resources, stringent environmental regulations, and geopolitical issues that affect mining operations. As a result, manufacturers often face challenges in sourcing the necessary raw materials, hampering the overall production capacity.

The limited availability of high-quality raw materials also affects the cost of production. As the demand for these materials surpasses the supply, prices tend to rise. This leads to increased production costs, which manufacturers may have to compensate for by either raising product prices or accepting reduced profit margins.

Key Market Trends

Growing Demand of Biocompatible Coatings

Biocompatible coatings refer to surfaces that are intricately designed to be in direct contact with living tissue without triggering any harmful reactions. These coatings are specifically engineered to ensure optimal compatibility, promoting seamless integration and functionality. One such remarkable material that exhibits exceptional biocompatibility and bioactivity is hydroxyapatite (HAp). Known as a naturally occurring mineral form of calcium apatite, HAp possesses unique properties that make it an ideal choice for creating biocompatible coatings.

The versatility of hydroxyapatite extends beyond orthopedic applications. Recent studies have shown promising results in utilizing hydroxyapatite coatings in cardiovascular applications. With the increasing prevalence of cardiovascular diseases, the demand for effective and biocompatible solutions is on the rise. Hydroxyapatite coatings have emerged as a potential solution, offering a combination of biocompatibility, durability, and performance.

The future of biocompatible coatings appears promising, driven by continuous advancements in the medical field and an unwavering focus on improving patient outcomes. As a result, the demand for hydroxyapatite is expected to experience significant growth, further propelling the expansion of the global hydroxyapatite market.

Segmental Insights

Type Insights

Based on the category of type, the nano-sized emerged as the fastest growing segment in the global market for hydroxyapatite in 2023.The concept of "nano-size hydroxyapatite" refers to the deliberate creation or alteration of hydroxyapatite particles, typically within the range of a few nanometers to several hundred nanometers. This specialized form of hydroxyapatite has become a focal point in the field of biomedicine, drawing considerable interest for its exceptional biocompatibility, osteoconductivity, and bioactivity.

Nano-sized hydroxyapatite holds immense potential across various applications within the biomedical sector. Its unique properties make it particularly well-suited for applications such as bone tissue engineering, where it can serve as a scaffold for promoting bone regeneration and repair. Its ability to interact favorably with biological systems makes it an ideal candidate for use in drug delivery systems, facilitating targeted and controlled release of pharmaceutical agents for enhanced therapeutic outcomes.

The exceptional biocompatibility of nano-sized hydroxyapatite ensures its compatibility with biological systems, minimizing adverse reactions and maximizing its usefulness in medical applications. Its osteoconductivity enables it to support bone growth and integration, making it an ideal candidate for bone tissue engineering.

Application Insights

The orthopedic segment is projected to experience rapid growth during the forecast period. The variables that contribute to an aging world population, such as increasing life expectancy and declining birth rates, along with the growing prevalence of age-related bone disorders and the rise in bone replacement procedures, are driving the demand for bioactive ceramics in the medical field. As the need for effective solutions for bone regeneration and restoration continues to grow, the market for bioactive ceramics is experiencing a significant surge in demand.

Regional Insights

North America emerged as the dominant player in the Global Hydroxyapatite Market in 2023, holding the largest market share in terms of both value and volume. In recent years, there has been a growing concern and awareness regarding dental health, leading to a significant 3.8% increase in the consumption of hydroxyapatite in North America. This rise can be attributed to the increasing focus on maintaining good oral hygiene and addressing dental issues in the region.

There has been a notable increase in expenditure to treat orthopedic issues, resulting in a 2.7% rise in the consumption of hydroxyapatite by the healthcare sector in North America. This indicates the growing recognition of hydroxyapatite's effectiveness in orthopedic treatments.

In Europe, the preference for cosmetic surgeries has been on the rise, leading to a 2.6% increase in demand for hydroxyapatite. This surge reflects the increasing desire for aesthetic enhancements and the trust placed in hydroxyapatite as a reliable component in cosmetic procedures. The research community has witnessed a boost in grants and scholarships dedicated to the study of ancient human lifestyle. As a result, there has been a 2.8% increase in the consumption of hydroxyapatite by research institutes, indicating its significance in conducting comprehensive studies and investigations.

Key Market Players

Sofsera Corporation

Taihei Chemical Industrial Co. Ltd

Cam Bioceramics BV

APS Materials Inc.

Granulab (M) Sdn Bhd

Berkeley Advanced Biomaterials Inc.

Zimmer Biomet Holdings Inc

CG Bio Inc.

Bio-Rad Laboratories Inc.

Fluidinova S.A.

Report Scope:

In this report, the Global Hydroxyapatite Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Hydroxyapatite Market,By Type:

• Nano-Sized
• Micro-Sized
• Greater than Micrometer

Hydroxyapatite Market,By Application:

• Orthopedic
• Plastic Surgery
• Dental Care
• Others

Hydroxyapatite Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Hydroxyapatite Market.

Available Customizations:

Global Hydroxyapatite Market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1.Product Overview

• 1.1.Market Definition
• 1.2.Scope of the Market
  • 1.2.1.Markets Covered
  • 1.2.2.Years Considered for Study
  • 1.2.3.Key Market Segmentations

2.Research Methodology

• 2.1.Objective of the Study
• 2.2.Baseline Methodology
• 2.3.Key Industry Partners
• 2.4.Major Association and Secondary Sources
• 2.5.Forecasting Methodology
• 2.6.Data Triangulation Validation
• 2.7.Assumptions and Limitations

3.Executive Summary

• 3.1.Overview of the Market
• 3.2.Overview of Key Market Segmentations
• 3.3.Overview of Key Market Players
• 3.4.Overview of Key Regions/Countries
• 3.5.Overview of Market Drivers, Challenges, Trends

4.Global Hydroxyapatite Market Outlook

• 4.1.Market Size Forecast
  • 4.1.1.By Value Volume
• 4.2.Market Share Forecast
  • 4.2.1. By Type (Nano-Sized, Micro-Sized, Greater than Micrometer)
  • 4.2.2. By Application (Orthopedic, Plastic Surgery, Dental Care, Others)
  • 4.2.3. By Region
  • 4.2.4.By Company (2023)
• 4.3.Market Map
  • 4.3.1.By Type
  • 4.3.2.By Application
  • 4.3.3.By Region

5.Asia Pacific Hydroxyapatite Market Outlook

• 5.1.Market Size Forecast
  • 5.1.1.By Value Volume
• 5.2.Market Share Forecast
  • 5.2.1. By Type
  • 5.2.2. By Application
  • 5.2.3.By Country
• 5.3.Asia Pacific: Country Analysis
  • 5.3.1.China Hydroxyapatite Market Outlook
    • 5.3.1.1.Market Size Forecast
      • 5.3.1.1.1.By Value Volume
    • 5.3.1.2.Market Share Forecast
      • 5.3.1.2.1.By Type
      • 5.3.1.2.2.By Application
  • 5.3.2.India Hydroxyapatite Market Outlook
    • 5.3.2.1.Market Size Forecast
      • 5.3.2.1.1.By Value Volume
    • 5.3.2.2.Market Share Forecast
      • 5.3.2.2.1.By Type
      • 5.3.2.2.2.By Application
  • 5.3.3.Australia Hydroxyapatite Market Outlook
    • 5.3.3.1.Market Size Forecast
      • 5.3.3.1.1.By Value Volume
    • 5.3.3.2.Market Share Forecast
      • 5.3.3.2.1.By Type
      • 5.3.3.2.2.By Application
  • 5.3.4.Japan Hydroxyapatite Market Outlook
    • 5.3.4.1.Market Size Forecast
      • 5.3.4.1.1.By Value Volume
    • 5.3.4.2.Market Share Forecast
      • 5.3.4.2.1.By Type
      • 5.3.4.2.2.By Application
  • 5.3.5.South Korea Hydroxyapatite Market Outlook
    • 5.3.5.1.Market Size Forecast
      • 5.3.5.1.1.By Value Volume
    • 5.3.5.2.Market Share Forecast
      • 5.3.5.2.1.By Type
      • 5.3.5.2.2.By Application

6.Europe Hydroxyapatite Market Outlook

• 6.1.Market Size Forecast
  • 6.1.1.By Value Volume
• 6.2.Market Share Forecast
  • 6.2.1. By Type
  • 6.2.2. By Application
  • 6.2.3. By Country
• 6.3.Europe: Country Analysis
  • 6.3.1.France Hydroxyapatite Market Outlook
    • 6.3.1.1.Market Size Forecast
      • 6.3.1.1.1.By Value Volume
    • 6.3.1.2.Market Share Forecast
      • 6.3.1.2.1.By Type
      • 6.3.1.2.2.By Application
  • 6.3.2.Germany Hydroxyapatite Market Outlook
    • 6.3.2.1.Market Size Forecast
      • 6.3.2.1.1.By Value Volume
    • 6.3.2.2.Market Share Forecast
      • 6.3.2.2.1.By Type
      • 6.3.2.2.2.By Application
  • 6.3.3.Spain Hydroxyapatite Market Outlook
    • 6.3.3.1.Market Size Forecast
      • 6.3.3.1.1.By Value Volume
    • 6.3.3.2.Market Share Forecast
      • 6.3.3.2.1.By Type
      • 6.3.3.2.2.By Application
  • 6.3.4.Italy Hydroxyapatite Market Outlook
    • 6.3.4.1.Market Size Forecast
      • 6.3.4.1.1.By Value Volume
    • 6.3.4.2.Market Share Forecast
      • 6.3.4.2.1.By Type
      • 6.3.4.2.2.By Application
  • 6.3.5.United Kingdom Hydroxyapatite Market Outlook
    • 6.3.5.1.Market Size Forecast
      • 6.3.5.1.1.By Value Volume
    • 6.3.5.2.Market Share Forecast
      • 6.3.5.2.1.By Type
      • 6.3.5.2.2.By Application

7.North America Hydroxyapatite Market Outlook

• 7.1.Market Size Forecast
  • 7.1.1.By Value Volume
• 7.2.Market Share Forecast
  • 7.2.1. By Type
  • 7.2.2. By Application
  • 7.2.3.By Country
• 7.3.North America: Country Analysis
  • 7.3.1.United States Hydroxyapatite Market Outlook
    • 7.3.1.1.Market Size Forecast
      • 7.3.1.1.1.By Value Volume
    • 7.3.1.2.Market Share Forecast
      • 7.3.1.2.1.By Type
      • 7.3.1.2.2.By Application
  • 7.3.2.Mexico Hydroxyapatite Market Outlook
    • 7.3.2.1.Market Size Forecast
      • 7.3.2.1.1.By Value Volume
    • 7.3.2.2.Market Share Forecast
      • 7.3.2.2.1.By Type
      • 7.3.2.2.2.By Application
  • 7.3.3.Canada Hydroxyapatite Market Outlook
    • 7.3.3.1.Market Size Forecast
      • 7.3.3.1.1.By Value Volume
    • 7.3.3.2.Market Share Forecast
      • 7.3.3.2.1.By Type
      • 7.3.3.2.2.By Application

8.South America Hydroxyapatite Market Outlook

• 8.1.Market Size Forecast
  • 8.1.1.By Value Volume
• 8.2.Market Share Forecast
  • 8.2.1. By Type
  • 8.2.2. By Application
  • 8.2.3.By Country
• 8.3.South America: Country Analysis
  • 8.3.1.Brazil Hydroxyapatite Market Outlook
    • 8.3.1.1.Market Size Forecast
      • 8.3.1.1.1.By Value Volume
    • 8.3.1.2.Market Share Forecast
      • 8.3.1.2.1.By Type
      • 8.3.1.2.2.By Application
  • 8.3.2.Argentina Hydroxyapatite Market Outlook
    • 8.3.2.1.Market Size Forecast
      • 8.3.2.1.1.By Value Volume
    • 8.3.2.2.Market Share Forecast
      • 8.3.2.2.1.By Type
      • 8.3.2.2.2.By Application
  • 8.3.3.Colombia Hydroxyapatite Market Outlook
    • 8.3.3.1.Market Size Forecast
      • 8.3.3.1.1.By Value Volume
    • 8.3.3.2.Market Share Forecast
      • 8.3.3.2.1.By Type
      • 8.3.3.2.2.By Application

9.Middle East and Africa Hydroxyapatite Market Outlook

• 9.1.Market Size Forecast
  • 9.1.1.By Value Volume
• 9.2.Market Share Forecast
  • 9.2.1. By Type
  • 9.2.2. By Application
  • 9.2.3.By Country
• 9.3.MEA: Country Analysis
  • 9.3.1.South Africa Hydroxyapatite Market Outlook
    • 9.3.1.1.Market Size Forecast
      • 9.3.1.1.1.By Value Volume
    • 9.3.1.2.Market Share Forecast
      • 9.3.1.2.1.By Type
      • 9.3.1.2.2.By Application
  • 9.3.2.Saudi Arabia Hydroxyapatite Market Outlook
    • 9.3.2.1.Market Size Forecast
      • 9.3.2.1.1.By Value Volume
    • 9.3.2.2.Market Share Forecast
      • 9.3.2.2.1.By Type
      • 9.3.2.2.2.By Application
  • 9.3.3.UAE Hydroxyapatite Market Outlook
    • 9.3.3.1.Market Size Forecast
      • 9.3.3.1.1.By Value Volume
    • 9.3.3.2.Market Share Forecast
      • 9.3.3.2.1.By Type
      • 9.3.3.2.2.By Application

10.Market Dynamics

• 10.1.Drivers
• 10.2.Challenges

11.Market Trends Developments

• 11.1.Recent Developments
• 11.2.Product Launches
• 11.3.Mergers Acquisitions

12.Global Hydroxyapatite Market: SWOT Analysis

13.Porter's Five Forces Analysis

• 13.1.Competition in the Industry
• 13.2.Potential of New Entrants
• 13.3.Power of Suppliers
• 13.4.Power of Customers
• 13.5.Threat of Substitute Product

14.Competitive Landscape

• 14.1. Sofsera Corporation
  • 14.1.1.Business Overview
  • 14.1.2.Company Snapshot
  • 14.1.3.Products Services
  • 14.1.4.Financials (As Reported)
  • 14.1.5.Recent Developments
• 14.2. Taihei Chemical Industrial Co. Ltd
• 14.3. Cam Bioceramics BV
• 14.4. APS Materials Inc.
• 14.5. Granulab (M) Sdn Bhd
• 14.6. Berkeley Advanced Biomaterials Inc.
• 14.7. Zimmer Biomet Holdings Inc
• 14.8. CG Bio Inc.
• 14.9. Bio-Rad Laboratories Inc.
• 14.10. Fluidinova S.A.

15.Strategic Recommendations

16.About Us Disclaimer